MOSCOW (Sputnik) - Russia's research centre Vector is working on a combined vaccine that would protect both against flu and COVID-19, Director Rinat Maksyutov said on Wednesday.
"Our centre is currently working on a combined vaccine against the coronavirus and seasonal flu," Maksyutov said at the Valdai Discussion Club forum.
He added that Russia's coronavirus vaccine, EpiVacCorona, developed by the Vector research centre, is absolutely safe both for elderly people and those suffering from allergies.
Russia registered the world's first coronavirus vaccine, Sputnik V, on 11 August. It was developed by the Gamaleya Research Institute and the Russian Direct Investment Fund (RDIF). The fund's CEO, Kirill Dmitriev, told the audience of the Valdai Discussion Club forum how the development of Sputnik V started.
Russian vaccine has been attacked in an attempt to discredit it as part of the geopolitical vaccine battle, CEO of the Russian Direct Investment Fund Kirill Dmitriev said.
"I think the participants here [at the session] are interested in this vaccine battle as an example of a geopolitical confrontation," RDIF CEO said.
According to Dmitriev, there are attacks on the vaccine and attempts to discredit it. RDIF CEO noted that the pharmaceutical industry was not very welcoming toward the new players.